Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 4 Grant or award Director acquired 6,500 shares (grant or award)
  2. 4 Grant or award Director acquired 6,500 shares (grant or award)
  3. 4 Grant or award Director acquired 6,500 shares (grant or award)
  4. 4 Grant or award Director acquired 6,500 shares (grant or award)
  5. 4 Grant or award Director acquired 6,500 shares (grant or award)
  6. 4 Grant or award Director acquired 6,500 shares (grant or award)
  7. 4 Grant or award Director acquired 6,500 shares (grant or award)
  8. 4 Grant or award Director acquired 6,500 shares (grant or award)
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event Other events
  13. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 54 shares at $6.74 ($364)
  14. ARS Other Annual Report to Security Holders
  15. DEFA14A Proxy Proxy Materials
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Other events
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. SC 13G/A Stake Amended Statement of Ownership

Page 18 of 65 · 1,286 filings